Metropolitan Life Insurance Co. NY lessened its stake in shares of Xylem Inc (NYSE:XYL) by 64.3% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 31,737 shares of the industrial products company’s stock after selling 57,199 shares during the period. Metropolitan Life Insurance Co. NY’s holdings in Xylem were worth $2,164,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Greenleaf Trust raised its holdings in Xylem by 97.4% during the fourth quarter. Greenleaf Trust now owns 1,490 shares of the industrial products company’s stock worth $102,000 after acquiring an additional 735 shares in the last quarter. Invictus RG bought a new stake in Xylem during the third quarter worth about $104,000. Hanson & Doremus Investment Management bought a new stake in Xylem during the fourth quarter worth about $126,000. FNY Partners Fund LP raised its holdings in Xylem by 2,700.0% during the third quarter. FNY Partners Fund LP now owns 2,800 shares of the industrial products company’s stock worth $175,000 after acquiring an additional 2,700 shares in the last quarter. Finally, Dorsey & Whitney Trust CO LLC bought a new stake in Xylem during the third quarter worth about $205,000. Institutional investors and hedge funds own 85.40% of the company’s stock.
In other news, Director Curtis J. Crawford sold 7,948 shares of the company’s stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $71.77, for a total value of $570,427.96. Following the transaction, the director now owns 55,245 shares of the company’s stock, valued at $3,964,933.65. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Tomas Brannemo sold 1,151 shares of the company’s stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $76.41, for a total value of $87,947.91. The disclosure for this sale can be found here. Insiders sold 21,105 shares of company stock worth $1,540,907 in the last ninety days. 0.75% of the stock is owned by company insiders.
Xylem (NYSE:XYL) last posted its earnings results on Thursday, February 1st. The industrial products company reported $0.76 EPS for the quarter, meeting the consensus estimate of $0.76. Xylem had a return on equity of 17.95% and a net margin of 7.03%. The company had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same quarter in the prior year, the business earned $0.66 earnings per share. The firm’s revenue for the quarter was up 16.6% on a year-over-year basis. equities analysts forecast that Xylem Inc will post 2.92 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Thursday, March 15th. Stockholders of record on Thursday, February 15th were given a $0.21 dividend. This is an increase from Xylem’s previous quarterly dividend of $0.18. The ex-dividend date of this dividend was Wednesday, February 14th. This represents a $0.84 annualized dividend and a dividend yield of 1.11%. Xylem’s dividend payout ratio is presently 45.65%.
XYL has been the topic of several analyst reports. BMO Capital Markets reiterated a “buy” rating and set a $86.00 target price on shares of Xylem in a report on Friday, February 2nd. Canaccord Genuity reissued a “hold” rating and set a $65.00 price target on shares of Xylem in a research report on Monday, December 11th. Boenning Scattergood reissued a “buy” rating on shares of Xylem in a research report on Friday, December 15th. Seaport Global Securities reissued a “buy” rating and set a $83.00 price target on shares of Xylem in a research report on Friday, February 2nd. Finally, Zacks Investment Research downgraded Xylem from a “buy” rating to a “hold” rating in a research report on Wednesday, December 6th. Five research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Xylem presently has a consensus rating of “Buy” and a consensus price target of $73.00.
Xylem Company Profile
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.